1 |
Pharmaceutical compositions, US patent 4,897,270 (1990)
|
2 |
A. Burger and K. T. Koller, Polymorphism and pseudopoly- morphism on nifedifine, Sci. Pharm., 64, 293-301 (1996)
|
3 |
J. W. Moore and H. H. Flanner, Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm. Tech., 20, 6, 64-74 (1996)
|
4 |
Harding S.M., Wiliams P.E.O., Ayrton J. Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteers, Antimicrob. Agents Chemother., 25, 78-82 (1984)
DOI
ScienceOn
|
5 |
Emmerson A. M., Cefuroxime axetil, J. Antimicrob. Chem other., 22, 101-103 (1988)
DOI
|
6 |
Dellamonica P., Cefuroxime axetil, Int J. Antimicrob. Agents., 4, 23-26 (1994)
DOI
ScienceOn
|
7 |
Oszczapowicz, I., Tejchman, B., Ziminiak, A. and Oszcza- powicz, J., Esters of cephalosporins. Part VI. Properties of the -form of 1-acetoxyethyl ester of cefuroxime, Acta Poloniae Pharmaceutica., 55, 3, 197-204 (1998)
|
8 |
Oszczapowicz, I., Malafiej, E., Horoszewicz-Malafiej, A., Szelachowska, M., Kuklewicz, C. and Sieranska, E., Esters of cephalosporins. Part III. Separation and properties of the R and S isomers of the 1-acetoxyethyl ester of cefuroxime, Acta Poloniae Pharmaceutica., 52, 6, 471-476 (1995)
|
9 |
USP XXIV, 2000, p.355-356
|
10 |
H. Zhu, B. E. Padden, E. J. Munson and D. J. W. Grant, Physicochemical characterization of nedocromil bivalent metal salt hydrate. 2. Nedocromil zinc, J. Pharm. Sci., 86, 418-429 (1997)
DOI
ScienceOn
|
11 |
A. David, E. Balogh, G. Csoka and I. Racz, Methodological aspects of examination of the polymorphism of vincristine sulfate, Sci. Pharm., 64, 311-318 (1996)
|
12 |
M. R. Caira, M. Zanol, t. Peveri, A. Gazzaniga and F. Gior- dano, Structural characterization of two polymorphic forms of piroxicam pivalate, J. Pharm. Sci., 87, 1608-1614 (1998)
DOI
ScienceOn
|
13 |
Ahlheck, C., and G. Zografi. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm., 62, 87 -95 (1990)
DOI
ScienceOn
|
14 |
Process for the preparation of cefuroxime axetil in an amorphous form, WO patent 99/65919 (1999)
|
15 |
V. P. Shah, Y. Tsong and P. Sathe, In vitro dissolution profile comparison statistics and analysis of the similarity factor, f2. Pharm. Res., 15, 889-896 (1998)
DOI
ScienceOn
|
16 |
Oszczapowicz, I., Malafiej, E., Szelachowska, M., Horosze- wicz-malafiej, A. Kuklewicz, C., Sieranska, E., Denys, A. and Niedworok, J. Esters of cephalosporins. Part II. Differences in the properties of various forms of the 1-acetoxyethyl ester of cefuroxime. Acta Poloniae Pharmaceutica, 52, 5, 397-401 (1995)
|
17 |
R. A. Lodder, M. Selby, and G. M. Hieftje, Detection of capsule tampering by Near-Infrared Reflectance analysis, Anal. Chem., 59, 1921-1930 (1987)
DOI
|
18 |
P. J. Gemperline and L. D. Webber, Raw materials testing using soft independent modeling of class analogy analysis of Near-Infrared Reflectance spectra. Anal. Chem., 61, 138-144 (1989)
DOI
|